Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

A Mechatronic Platform for Computer Aided Detection of Nodules in Anatomopathological Analyses via Stiffness and Ultrasound Measurements.

Massari L, Bulletti A, Prasanna S, Mazzoni M, Frosini F, Vicari E, Pantano M, Staderini F, Ciuti G, Cianchi F, Messerini L, Capineri L, Menciassi A, Oddo CM.

Sensors (Basel). 2019 May 31;19(11). pii: E2512. doi: 10.3390/s19112512.

2.

RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy.

Mini E, Lapucci A, Perrone G, D'Aurizio R, Napoli C, Brugia M, Landini I, Tassi R, Picariello L, Simi L, Mancini I, Messerini L, Magi A, Pinzani P, Mazzei T, Tonelli F, Nobili S.

Int J Cancer. 2019 Nov 1;145(9):2580-2593. doi: 10.1002/ijc.32326. Epub 2019 Jun 3.

PMID:
30973654
3.

Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II/III colorectal cancer patients who benefit from adjuvant chemotherapy.

Allen WL, Dunne PD, McDade S, Scanlon E, Loughrey M, Coleman H, McCann C, McLaughlin K, Nemeth Z, Syed N, Jithesh P, Arthur K, Wilson R, Coyle V, McArt D, Murray GI, Samuel L, Nuciforo P, Jimenez J, Argiles G, Dienstmann R, Tabernero J, Messerini L, Nobili S, Mini E, Sheahan K, Ryan E, Johnston PG, Van Schaeybroeck S, Lawler M, Longley DB.

JCO Precis Oncol. 2018 Jun 13;2018. doi: 10.1200/PO.17.00241.

4.

Poor pathogenetic role of luminal obstruction in the development of appendicitis: A case report.

Giudici F, Scaringi S, Zambonin D, Voglino C, Messerini L, Ficari F, Bechi P.

Medicine (Baltimore). 2018 Apr;97(15):e0381. doi: 10.1097/MD.0000000000010381.

5.

Ki67 proliferative index of the neuroendocrine component drives MANEC prognosis.

Milione M, Maisonneuve P, Pellegrinelli A, Grillo F, Albarello L, Spaggiari P, Vanoli A, Tagliabue G, Pisa E, Messerini L, Centonze G, Inzani F, Scarpa A, Papotti M, Volante M, Sessa F, Fazio N, Pruneri G, Rindi G, Solcia E, La Rosa S, Capella C.

Endocr Relat Cancer. 2018 May;25(5):583-593. doi: 10.1530/ERC-17-0557. Epub 2018 Mar 28.

PMID:
29592868
6.

Primary jejunal interdigitating dendritic cell sarcoma.

Guerra F, Vegni A, Perna F, Messerini L, Coratti A.

Ann Diagn Pathol. 2018 Feb;32:1-3. doi: 10.1016/j.anndiagpath.2017.08.001. Epub 2017 Aug 18. No abstract available.

PMID:
29414390
7.

Gastric and duodenal polyps in familial adenomatous polyposis patients: Conventional endoscopy vs virtual chromoendoscopy (fujinon intelligent color enhancement) in dysplasia evaluation.

Lami G, Galli A, Macrì G, Dabizzi E, Biagini MR, Tarocchi M, Messerini L, Valanzano R, Milani S, Polvani S.

World J Clin Oncol. 2017 Apr 10;8(2):168-177. doi: 10.5306/wjco.v8.i2.168.

8.

hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy.

Muratori L, Petroni G, Antonuzzo L, Boni L, Iorio J, Lastraioli E, Bartoli G, Messerini L, Di Costanzo F, Arcangeli A.

Onco Targets Ther. 2016 Oct 14;9:6325-6332. eCollection 2016.

9.

DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.

Bigagli E, De Filippo C, Castagnini C, Toti S, Acquadro F, Giudici F, Fazi M, Dolara P, Messerini L, Tonelli F, Luceri C.

Cell Oncol (Dordr). 2016 Dec;39(6):545-558. Epub 2016 Oct 5.

PMID:
27709558
10.

Robotic vs laparoscopic distal gastrectomy with D2 lymphadenectomy for gastric cancer: a retrospective comparative mono-institutional study.

Cianchi F, Indennitate G, Trallori G, Ortolani M, Paoli B, Macrì G, Lami G, Mallardi B, Badii B, Staderini F, Qirici E, Taddei A, Ringressi MN, Messerini L, Novelli L, Bagnoli S, Bonanomi A, Foppa C, Skalamera I, Fiorenza G, Perigli G.

BMC Surg. 2016 Sep 20;16(1):65. doi: 10.1186/s12893-016-0180-z.

11.

hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance.

Lastraioli E, Lottini T, Iorio J, Freschi G, Fazi M, Duranti C, Carraresi L, Messerini L, Taddei A, Ringressi MN, Salemme M, Villanacci V, Vindigni C, Tomezzoli A, La Mendola R, Bencivenga M, Compagnoni B, Chiudinelli M, Saragoni L, Manzi I, De Manzoni G, Bechi P, Boni L, Arcangeli A.

Oncotarget. 2016 Sep 13;7(37):59535-59547. doi: 10.18632/oncotarget.11149.

12.

KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: a population-based study.

Rossi S, Gasparotto D, Miceli R, Toffolatti L, Gallina G, Scaramel E, Marzotto A, Boscato E, Messerini L, Bearzi I, Mazzoleni G, Capella C, Arrigoni G, Sonzogni A, Sidoni A, Mariani L, Amore P, Gronchi A, Casali PG, Maestro R, Dei Tos AP.

Am J Surg Pathol. 2015 Jul;39(7):922-30. doi: 10.1097/PAS.0000000000000418.

PMID:
25970686
13.

Survival after laparoscopic and open surgery for colon cancer: a comparative, single-institution study.

Cianchi F, Trallori G, Mallardi B, Macrì G, Biagini MR, Lami G, Indennitate G, Bagnoli S, Bonanomi A, Messerini L, Badii B, Staderini F, Skalamera I, Fiorenza G, Perigli G.

BMC Surg. 2015 Mar 25;15:33. doi: 10.1186/s12893-015-0013-5.

14.

Squamous cell carcinoma of the middle rectum: Report of a case and literature overview.

Scaringi S, Bisogni D, Messerini L, Bechi P.

Int J Surg Case Rep. 2015;7C:127-9. doi: 10.1016/j.ijscr.2014.10.097. Epub 2014 Nov 5.

15.
16.

Telocytes are reduced during fibrotic remodelling of the colonic wall in ulcerative colitis.

Manetti M, Rosa I, Messerini L, Ibba-Manneschi L.

J Cell Mol Med. 2015 Jan;19(1):62-73. doi: 10.1111/jcmm.12457. Epub 2014 Oct 6.

17.

Gallbladder neuroendocrine neoplasm: a case report and critical evaluation of WHO classification.

Meoni G, Antonuzzo L, Messerini L, Giommoni E, Muto A, Petreni P, Vannini A, Lunghi A, Molinara E, Di Costanzo F.

Endocr J. 2014;61(10):989-94. Epub 2014 Aug 2.

18.

Aminorex associated with possible idiopathic pulmonary hypertension in a cocaine user.

Karch SB, Defraia B, Messerini L, Mari F, Vaiano F, Bertol E.

Forensic Sci Int. 2014 Jul;240:e7-10. doi: 10.1016/j.forsciint.2014.03.028. Epub 2014 Apr 6.

PMID:
24794740
19.

VEGF-A clinical significance in gastric cancers: immunohistochemical analysis of a wide Italian cohort.

Lastraioli E, Boni L, Romoli MR, Crescioli S, Taddei A, Beghelli S, Tomezzoli A, Vindigni C, Saragoni L, Messerini L, Bernini M, Bencini L, Giommoni E, Freschi G, Di Costanzo F, Scarpa A, Morgagni P, Farsi M, Roviello F, De Manzoni G, Bechi P, Arcangeli A; Gruppo Italiano di Ricerca Cancro Gastrico (GIRCG).

Eur J Surg Oncol. 2014 Oct;40(10):1291-8. doi: 10.1016/j.ejso.2014.03.028. Epub 2014 Apr 12.

PMID:
24784776
20.

A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis.

Manetti M, Rosa I, Messerini L, Guiducci S, Matucci-Cerinic M, Ibba-Manneschi L.

J Cell Mol Med. 2014 Feb;18(2):253-62. doi: 10.1111/jcmm.12228.

21.

hERG1 channels regulate VEGF-A secretion in human gastric cancer: clinicopathological correlations and therapeutical implications.

Crociani O, Lastraioli E, Boni L, Pillozzi S, Romoli MR, D'Amico M, Stefanini M, Crescioli S, Masi A, Taddei A, Bencini L, Bernini M, Farsi M, Beghelli S, Scarpa A, Messerini L, Tomezzoli A, Vindigni C, Morgagni P, Saragoni L, Giommoni E, Gasperoni S, Di Costanzo F, Roviello F, De Manzoni G, Bechi P, Arcangeli A.

Clin Cancer Res. 2014 Mar 15;20(6):1502-12. doi: 10.1158/1078-0432.CCR-13-2633. Epub 2014 Jan 21. Erratum in: Clin Cancer Res. 2014 Aug 1;20(15):4168-9. Clin Cancer Res. 2014 May 1;20(9):2501. Masi, Alessio [added].

22.

Cyclooxygenase-2 and inflammation mediators have a crucial role in reflux-related esophageal histological changes and Barrett's esophagus.

Taddei A, Fabbroni V, Pini A, Lucarini L, Ringressi MN, Fantappiè O, Bani D, Messerini L, Masini E, Bechi P.

Dig Dis Sci. 2014 May;59(5):949-57. doi: 10.1007/s10620-013-2975-4. Epub 2013 Dec 20.

PMID:
24357184
23.

Integrative analysis of hereditary nonpolyposis colorectal cancer: the contribution of allele-specific expression and other assays to diagnostic algorithms.

De Lellis L, Aceto GM, Curia MC, Catalano T, Mammarella S, Veschi S, Fantini F, Battista P, Stigliano V, Messerini L, Mareni C, Sala P, Bertario L, Radice P, Cama A.

PLoS One. 2013 Nov 20;8(11):e81194. doi: 10.1371/journal.pone.0081194. eCollection 2013.

24.

Telocytes in Crohn's disease.

Milia AF, Ruffo M, Manetti M, Rosa I, Conte D, Fazi M, Messerini L, Ibba-Manneschi L.

J Cell Mol Med. 2013 Dec;17(12):1525-36. doi: 10.1111/jcmm.12177. Epub 2013 Nov 19.

25.

Trends in colorectal incidence by anatomic subsite from 1985 to 2005: a population-based study.

Caldarella A, Crocetti E, Messerini L, Paci E.

Int J Colorectal Dis. 2013 May;28(5):637-41. doi: 10.1007/s00384-013-1672-2. Epub 2013 Mar 12.

PMID:
23478843
26.

Neoadjuvant oxaliplatin and 5-fluorouracil with concurrent radiotherapy in patients with locally advanced rectal cancer: a single-institution experience.

Greto D, Paiar F, Saieva C, Galardi A, Mangoni M, Livi L, Agresti B, Franceschini D, Bonomo P, Scotti V, Detti B, Tonelli F, Valeri A, Messerini L, Biti G.

Radiol Med. 2013 Jun;118(4):570-82. doi: 10.1007/s11547-012-0909-4. Epub 2013 Jan 28.

PMID:
23358814
27.

Totally laparoscopic versus open gastrectomy for gastric cancer: a matched cohort study.

Cianchi F, Qirici E, Trallori G, Macrì G, Indennitate G, Ortolani M, Paoli B, Biagini MR, Galli A, Messerini L, Mallardi B, Badii B, Staderini F, Perigli G.

J Laparoendosc Adv Surg Tech A. 2013 Feb;23(2):117-22. doi: 10.1089/lap.2012.0310. Epub 2012 Dec 10.

PMID:
23216509
28.

 Glycogenic hepatopathy associated with type 1 diabetes mellitus as a cause of recurrent liver damage.

Messeri S, Messerini L, Vizzutti F, Laffi G, Marra F.

Ann Hepatol. 2012 Jul-Aug;11(4):554-8.

29.

hERG1 Channels and Glut-1 as Independent Prognostic Indicators of Worse Outcome in Stage I and II Colorectal Cancer: A Pilot Study.

Lastraioli E, Bencini L, Bianchini E, Romoli MR, Crociani O, Giommoni E, Messerini L, Gasperoni S, Moretti R, Di Costanzo F, Boni L, Arcangeli A.

Transl Oncol. 2012 Apr;5(2):105-12. Epub 2012 Apr 1.

30.

Adequacy of lymphadenectomy in laparoscopic colorectal cancer surgery: a single-centre, retrospective study.

Cianchi F, Cortesini C, Trallori G, Messerini L, Novelli L, Comin CE, Qirici E, Bonanomi A, Macrì G, Badii B, Kokomani A, Perigli G.

Surg Laparosc Endosc Percutan Tech. 2012 Feb;22(1):33-7. doi: 10.1097/SLE.0b013e31824332dc.

PMID:
22318057
31.

Natural history of imatinib-naive GISTs: a retrospective analysis of 929 cases with long-term follow-up and development of a survival nomogram based on mitotic index and size as continuous variables.

Rossi S, Miceli R, Messerini L, Bearzi I, Mazzoleni G, Capella C, Arrigoni G, Sonzogni A, Sidoni A, Toffolatti L, Laurino L, Mariani L, Vinaccia V, Gnocchi C, Gronchi A, Casali PG, Dei Tos AP.

Am J Surg Pathol. 2011 Nov;35(11):1646-56. doi: 10.1097/PAS.0b013e31822d63a7.

PMID:
21997685
32.

Apoptotic proteins as prognostic markers and indicators of radiochemosensitivity in stage II/III rectal cancers.

Fucini C, Messerini L, Saieva C, Orzalesi L, Carroni V, Bartolini N.

Colorectal Dis. 2012 Feb;14(2):e64-71. doi: 10.1111/j.1463-1318.2011.02763.x.

PMID:
21848899
33.

Hepatoid adenocarcinoma of the ureter: unusual case presenting hepatic and ovarian metastases.

Rotellini M, Messerini L, Stomaci N, Raspollini MR.

Appl Immunohistochem Mol Morphol. 2011 Oct;19(5):478-83. doi: 10.1097/PAI.0b013e318216af63.

PMID:
21558843
34.

Colorectal tumors: the histology report.

Lanza G, Messerini L, Gafà R, Risio M; Gruppo Italiano Patologi Apparato Digerente (GIPAD); Società Italiana di Anatomia Patologica e Citopatologia Diagnostica/International Academy of Pathology, Italian division (SIAPEC/IAP).

Dig Liver Dis. 2011 Mar;43 Suppl 4:S344-55. doi: 10.1016/S1590-8658(11)60590-2.

PMID:
21459340
35.

Gastrointestinal stromal tumors: the histology report.

Dei Tos AP, Laurino L, Bearzi I, Messerini L, Farinati F; Gruppo Italiano Patologi Apparato Digerente (GIPAD); Società Italiana di Anatomia Patologica e Citopatologia Diagnostica/International Academy of Pathology, Italian division (SIAPEC/IAP).

Dig Liver Dis. 2011 Mar;43 Suppl 4:S304-9. doi: 10.1016/S1590-8658(11)60586-0.

PMID:
21459336
36.

The impact of histopathologic examination of graft-versus-host disease in the era of reduced-intensity conditioning regimen: a study from the Gruppo Italiano Trapianto di Midollo Osseo.

Massi D, Fondi C, Nozzoli C, Benemei S, Lapi F, Albarello L, Avellini C, Bonoldi E, Casini M, Cesinaro AM, Ciceri F, Colombetti V, Comin CE, Donelli A, Fortunato M, Fratoni S, Guidi S, Messerini L, Milone G, Rapezzi D, Negri G, Patriarca F, Peccatori FA, Ponzoni M, Rafaniello P, Raimondi R, Salomone E, Tendas A, Villari L, Santucci M, Bosi A.

Hum Pathol. 2011 Feb;42(2):254-68. doi: 10.1016/j.humpath.2010.07.004. Epub 2010 Nov 24.

PMID:
21106223
37.

The gastric wall in systemic sclerosis patients: a morphological study.

Manetti M, Milia AF, Benelli G, Messerini L, Matucci-Cerinic M, Ibba-Manneschi L.

Ital J Anat Embryol. 2010;115(1-2):115-21.

PMID:
21073000
38.

Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size.

Rossi S, Gasparotto D, Toffolatti L, Pastrello C, Gallina G, Marzotto A, Sartor C, Barbareschi M, Cantaloni C, Messerini L, Bearzi I, Arrigoni G, Mazzoleni G, Fletcher JA, Casali PG, Talamini R, Maestro R, Dei Tos AP.

Am J Surg Pathol. 2010 Oct;34(10):1480-91. doi: 10.1097/PAS.0b013e3181ef7431. Erratum in: Am J Surg Pathol. 2011 May;35(5):781. Maestra, Roberta [corrected to Maestro, Roberta].

PMID:
20861712
39.

Prognostic relevance of MLH1 and MSH2 mutations in hereditary non-polyposis colorectal cancer patients.

Russo A, Sala P, Alberici P, Gazzoli I, Radice P, Montefusco C, Torrini M, Mareni C, Fornasarig M, Santarosa M, Viel A, Benatti P, Pedroni M, de Leon MP, Lucci-Cordisco E, Genuardi M, Messerini L, Stigliano V, Cama A, Curia MC, de Lellis L, Signoroni S, Pierotti MA, Bertario L.

Tumori. 2009 Nov-Dec;95(6):731-8. Erratum in: Tumori. 2010 Jan-Feb;96(1):183. Pedroni, Maurizio [corrected to Pedroni, Monica].

PMID:
20210238
40.

Evidence for the prevention of enthesitis in HLA-B27/hβ(2)m transgenic rats treated with a monoclonal antibody against TNF-α.

Milia AF, Ibba-Manneschi L, Manetti M, Benelli G, Generini S, Messerini L, Matucci-Cerinic M.

J Cell Mol Med. 2011 Feb;15(2):270-9. doi: 10.1111/j.1582-4934.2009.00984.x.

41.

HLA-B27 transgenic rat: an animal model mimicking gut and joint involvement in human spondyloarthritides.

Milia AF, Ibba-Manneschi L, Manetti M, Benelli G, Messerini L, Matucci-Cerinic M.

Ann N Y Acad Sci. 2009 Sep;1173:570-4. doi: 10.1111/j.1749-6632.2009.04757.x. Review.

PMID:
19758201
42.

Reduction of colonic inflammation in HLA-B27 transgenic rats by feeding Marie Ménard apples, rich in polyphenols.

Castagnini C, Luceri C, Toti S, Bigagli E, Caderni G, Femia AP, Giovannelli L, Lodovici M, Pitozzi V, Salvadori M, Messerini L, Martin R, Zoetendal EG, Gaj S, Eijssen L, Evelo CT, Renard CM, Baron A, Dolara P.

Br J Nutr. 2009 Dec;102(11):1620-8. doi: 10.1017/S0007114509990936. Epub 2009 Jul 22.

PMID:
19622193
43.

Heterogeneous expression of cyclooxygenase-2 and inducible nitric oxide synthase within colorectal tumors: correlation with tumor angiogenesis.

Cianchi F, Cuzzocrea S, Vinci MC, Messerini L, Comin CE, Navarra G, Perigli G, Centorrino T, Marzocco S, Lenzi E, Battisti N, Trallori G, Masini E.

Dig Liver Dis. 2010 Jan;42(1):20-7. doi: 10.1016/j.dld.2009.04.010. Epub 2009 Jun 3.

PMID:
19497798
44.

Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells.

Cianchi F, Papucci L, Schiavone N, Lulli M, Magnelli L, Vinci MC, Messerini L, Manera C, Ronconi E, Romagnani P, Donnini M, Perigli G, Trallori G, Tanganelli E, Capaccioli S, Masini E.

Clin Cancer Res. 2008 Dec 1;14(23):7691-700. doi: 10.1158/1078-0432.CCR-08-0799.

45.

NF2 expression levels of gastrointestinal stromal tumors: a quantitative real-time PCR study.

Taddei A, Castiglione F, Rossi Degl'Innocenti D, Buccoliero AM, Garbini F, Tommasi C, Freschi G, Bechi P, Messerini L, Taddei GL.

Tumori. 2008 Jul-Aug;94(4):551-5.

PMID:
18822692
46.

Solitary necrotic nodules of the liver: cross-sectional imaging findings and follow-up in nine patients.

Colagrande S, Paolucci ML, Messerini L, Schima W, Stadler A, Bartolotta TV, Vanzulli A, Brancatelli G.

AJR Am J Roentgenol. 2008 Oct;191(4):1122-8. doi: 10.2214/AJR.07.3488.

PMID:
18806154
47.

Endothelial/lymphocyte activation leads to prominent CD4+ T cell infiltration in the gastric mucosa of patients with systemic sclerosis.

Manetti M, Neumann E, Müller A, Schmeiser T, Saar P, Milia AF, Endlicher E, Roeb E, Messerini L, Matucci-Cerinic M, Ibba-Manneschi L, Müller-Ladner U.

Arthritis Rheum. 2008 Sep;58(9):2866-73. doi: 10.1002/art.23806.

48.

Functional polymorphisms of the microsomal epoxide hydrolase gene: a reappraisal on a early-onset lung cancer patients series.

Graziano C, Comin CE, Crisci C, Novelli L, Politi L, Messerini L, Andreani M, Porfirio B.

Lung Cancer. 2009 Feb;63(2):187-93. doi: 10.1016/j.lungcan.2008.05.004. Epub 2008 Jun 20.

PMID:
18571762
49.

TNFalpha blockade prevents the development of inflammatory bowel disease in HLA-B27 transgenic rats.

Milia AF, Manetti M, Generini S, Polidori L, Benelli G, Cinelli M, Messerini L, Ibba-Manneschi L, Matucci-Cerinic M.

J Cell Mol Med. 2009 Jan;13(1):164-76. doi: 10.1111/j.1582-4934.2008.00310.x. Epub 2008 Mar 19.

50.

Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.

Di Costanzo F, Gasperoni S, Manzione L, Bisagni G, Labianca R, Bravi S, Cortesi E, Carlini P, Bracci R, Tomao S, Messerini L, Arcangeli A, Torri V, Bilancia D, Floriani I, Tonato M; Italian Oncology Group for Cancer Research, Dinota A, Strafiuso G, Corgna E, Porrozzi S, Boni C, Rondini E, Giunta A, Monzio Compagnoni B, Biagioni F, Cesari M, Fornarini G, Nelli F, Carboni M, Cognetti F, Enzo MR, Piga A, Romiti A, Olivetti A, Masoni L, De Stefanis M, Dalla Mola A, Camera S, Recchia F, De Filippis S, Scipioni L, Zironi S, Luppi G, Italia M, Banducci S, Pisani Leretti A, Massidda B, Ionta MT, Nicolosi A, Canaletti R, Biscottini B, Grigniani F, Di Costanzo F, Rovei R, Croce E, Carroccio R, Gilli G, Cavalli C, Olgiati A, Pandolfi U, Rossetti R, Natalini G, Foa P, Oldani S, Bruno L, Cascinu S, Catalano G, Catalano V, Lungarotti F, Farris A, Sarobba MG, Trignano M, Muscogiuri A, Francavilla F, Figoli F, Leoni M, Papiani G, Orselli G, Antimi M, Bellini V, Cabassi A, Contu A, Pazzola A, Frignano M, Lastraioli E, Saggese M, Bianchini D, Antonuzzo L, Mela M, Camisa R.

J Natl Cancer Inst. 2008 Mar 19;100(6):388-98. doi: 10.1093/jnci/djn054. Epub 2008 Mar 11.

PMID:
18334706

Supplemental Content

Loading ...
Support Center